Medicare billing address
CMS Medicare provider billing file
617 E Riverside Dr Ste 301Saint George, UT 84790
CMS public data · NPI 1023151644
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Spencer G Wells, M.D.
Specialty
Credential
M.D.
NPI
1023151644
Primary source state
UT
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Spencer G Wells, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
617 E Riverside Dr Ste 301CMS Doctors & Clinicians file
617 E Riverside DrCMS Doctors & Clinicians file
617 E Riverside DrCMS Doctors & Clinicians file
340 Falcon Ridge PkwyIn the 2024 CMS provider billing file, this NPI had 884 Medicare beneficiaries and 11,502.5 total services. The average beneficiary age was 76, and the average HCC risk score was 1.3.
Total Medicare allowed amount
$794,136.46
Total Medicare payment amount
$637,147.55
Medicare beneficiaries
884
Total services
11,502.5
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
71%
CMS beneficiary-panel share
Mood disorders
31%
CMS beneficiary-panel share
Depression
29%
CMS beneficiary-panel share
Ischemic heart disease
26%
CMS beneficiary-panel share
Anxiety
26%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 6,924 | $0.97 |
| Injection, midazolam hydrochloride, per 1 mg | 416 | $0.14 |
| Injection of substance into lower spine canal using imaging guidance | 306 | $262.79 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 303 | $130.60 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 298 | $194.77 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 244 | $287.61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 167 | $51.25 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 162 | $113.94 |
| Fluoroscopic guidance for needle placement | 158 | $118.29 |
| Injection, fentanyl citrate, 0.1 mg | 156.5 | $0.92 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1023151644. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 101 | 101 | $2,424.90 |
| 2 | Tramadol Hcl | Tramadol Hcl | 68 | 68 | $467.40 |
| 3 | Gabapentin | Gabapentin | 65 | 77.1 | $1,376.34 |
| 4 | Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 36 | 36 | $853.05 |
| 5 | Pregabalin | Pregabalin | 31 | 31 | $205.84 |
| 6 | Cephalexin | Cephalexin | 26 | 26 | $167.32 |
| 7 | Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 25 | 25 | $415.41 |
| 8 | Hydromorphone Hcl | Hydromorphone Hcl | 16 | 16 | $204.28 |
| 9 | Oxycodone Hcl | Oxycodone Hcl | 15 | 15 | $278.51 |
| 10 | Tizanidine Hcl | Tizanidine Hcl | 15 | 23 | $164.10 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Louisville School Of Medicine
Graduation year
2006
Group/practice field
Desert Pain Specialists Llc
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.